Ohmura-Hoshino Mari, Miyaki Yuki, Yashima Shigeko
Department of Medical Technology, School of Nursing and Medical Care, Yokkaichi Nursing and Medical Care University, Yokkaichi, Japan.
Laboratory, Komaki Hospital, Japan.
Heliyon. 2022 Aug 18;8(8):e10231. doi: 10.1016/j.heliyon.2022.e10231. eCollection 2022 Aug.
Human diarrhea-causing strains of are referred to as diarrheagenic (DEC). DEC can be divided into five main categories based on distinct epidemiological and clinical features, specific virulence determinants, and association with certain serotypes. In the present study, a simple and rapid one-step single reaction multiplex PCR (mPCR) assay was developed for the simultaneous identification and differentiation of five currently established pathotypes causing gastrointestinal diseases. The mPCR incorporated 10 primer pairs to amplify 10 virulence genes specific to the different pathotypes (i.e., 1 and 2 for EHEC, and for ETEC, A and A for EPEC, R and astA for EAEC, and H and E for EIEC) and to generate DNA fragments of sufficiently different sizes to be unequivocally resolved. All strains were detected at concentrations ranging from 10 to 10 CFU/mL. To demonstrate the utility of the mPCR assay, 236 clinically isolated strains of DEC from two hospitals were successfully categorized. One-step mPCR technique reduced the cost and effort involved in the identification of various virulence factors in DEC. Thus, we demonstrated that the newly developed mPCR assay has the potential to be introduced as a diagnostic tool that can be utilized for the detection of DEC as an additional check in clinical laboratories and for confirmation in health and environment institutes, health centers, and reference laboratories.
引起人类腹泻的菌株被称为致泻性大肠杆菌(DEC)。根据不同的流行病学和临床特征、特定的毒力决定因素以及与某些血清型的关联,DEC可分为五大类。在本研究中,开发了一种简单快速的一步单反应多重PCR(mPCR)检测方法,用于同时鉴定和区分目前确定的五种引起胃肠道疾病的大肠杆菌致病型。该mPCR包含10对引物,以扩增不同致病型特有的10个毒力基因(即肠出血性大肠杆菌的1和2、产肠毒素大肠杆菌的 和 、肠致病性大肠杆菌的A和A、肠集聚性大肠杆菌的R和astA,以及肠侵袭性大肠杆菌的H和E),并产生大小差异足够大以便能明确分辨的DNA片段。所有菌株在浓度范围为10到10 CFU/mL时均能被检测到。为了证明mPCR检测方法的实用性,对来自两家医院的236株临床分离的DEC菌株成功进行了分类。一步mPCR技术降低了鉴定DEC中各种毒力因子所涉及的成本和工作量。因此,我们证明新开发的mPCR检测方法有潜力作为一种诊断工具引入,可用于在临床实验室作为额外检查来检测DEC,并在健康与环境机构、健康中心及参考实验室进行确认。